Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
138148-60-4
2906-60-7
162515-67-5
857481-16-4
81560-09-0 | 5-Bromo-2-(methylthio)-4-methoxypyrimidine | AA005JR7 | MFCD07781215
69198-37-4 | 4-Allyl-5-(4-methoxybenzyl)-4h-1,2,4-triazole-3-thiol | AA005KIB | MFCD03945806
791850-21-0 | (2R)-2-[(4-Nitrophenyl)amino]propanoic acid | AA005L9C | MFCD04114467
69025-13-4 | 3-Chloro-6-(4-chlorophenoxy)pyridazine | AA005M30 | MFCD02946318
73025-69-1 | (R)-3-Amino-3-(4-hydroxyphenyl)propanoic acid hydrochloride | AA005MZ1 | MFCD04113666
78995-98-9 | β-Cyclocitral-d5 | AA005NPZ | MFCD09840289
68695-48-7 | Tetra-n-butylammonium di-tert-butylphosphate | AA005OJ2 | MFCD12198885
67868-84-2 | 2-Hydroxy-5-(methylthio)benzaldehyde | AA005P54 | MFCD03309091
717893-10-2 | 2-AMINO-N-(3-METHYLBENZYL)BENZAMIDE | AA005PR1 | MFCD06003243
7168-93-6 | 6-Methoxybenzo[d][1,3]dioxole-5-carboxylic acid | AA005QMZ | MFCD16061365